Concepts (176)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Food Hypersensitivity | 7 | 2022 | 186 | 1.870 |
Why?
|
| Immunologic Deficiency Syndromes | 3 | 2021 | 212 | 1.130 |
Why?
|
| Arthropod Venoms | 1 | 2023 | 7 | 0.810 |
Why?
|
| Ants | 1 | 2023 | 7 | 0.810 |
Why?
|
| Insect Bites and Stings | 1 | 2023 | 40 | 0.780 |
Why?
|
| Anaphylaxis | 2 | 2023 | 93 | 0.770 |
Why?
|
| Allergens | 3 | 2022 | 341 | 0.590 |
Why?
|
| Hypersensitivity | 2 | 2018 | 227 | 0.550 |
Why?
|
| Asthma | 4 | 2018 | 914 | 0.540 |
Why?
|
| Nut and Peanut Hypersensitivity | 1 | 2016 | 2 | 0.510 |
Why?
|
| Sesamum | 1 | 2016 | 3 | 0.500 |
Why?
|
| Nut Hypersensitivity | 1 | 2016 | 8 | 0.500 |
Why?
|
| Desensitization, Immunologic | 1 | 2018 | 117 | 0.490 |
Why?
|
| Arachis | 1 | 2016 | 76 | 0.470 |
Why?
|
| Peanut Hypersensitivity | 1 | 2016 | 88 | 0.450 |
Why?
|
| Mast Cells | 3 | 2021 | 66 | 0.420 |
Why?
|
| Immunoglobulin E | 4 | 2022 | 215 | 0.370 |
Why?
|
| Tryptases | 2 | 2021 | 17 | 0.330 |
Why?
|
| Anti-Allergic Agents | 2 | 2021 | 28 | 0.300 |
Why?
|
| Arylsulfonates | 1 | 2007 | 3 | 0.270 |
Why?
|
| Sulfonium Compounds | 1 | 2007 | 5 | 0.270 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2007 | 134 | 0.230 |
Why?
|
| Monocytes | 1 | 2007 | 337 | 0.230 |
Why?
|
| Dendritic Cells | 1 | 2007 | 437 | 0.210 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2004 | 134 | 0.210 |
Why?
|
| Child, Preschool | 8 | 2023 | 14945 | 0.210 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2004 | 92 | 0.190 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 2022 | 70 | 0.180 |
Why?
|
| Urticaria | 1 | 2021 | 19 | 0.170 |
Why?
|
| Humans | 21 | 2023 | 130483 | 0.160 |
Why?
|
| Skin Tests | 2 | 2018 | 100 | 0.160 |
Why?
|
| Mastocytosis, Systemic | 1 | 2020 | 8 | 0.160 |
Why?
|
| Hypereosinophilic Syndrome | 1 | 2020 | 8 | 0.160 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2021 | 218 | 0.160 |
Why?
|
| Antigens, Dermatophagoides | 2 | 2018 | 14 | 0.160 |
Why?
|
| Metabolic Diseases | 1 | 2021 | 140 | 0.150 |
Why?
|
| Cell Differentiation | 1 | 2007 | 1930 | 0.150 |
Why?
|
| Malnutrition | 1 | 2021 | 155 | 0.150 |
Why?
|
| Young Adult | 3 | 2018 | 10010 | 0.140 |
Why?
|
| Artemia | 1 | 2018 | 2 | 0.140 |
Why?
|
| Pyroglyphidae | 1 | 2018 | 9 | 0.140 |
Why?
|
| Adolescent | 6 | 2021 | 20737 | 0.140 |
Why?
|
| Cross Reactions | 1 | 2018 | 159 | 0.140 |
Why?
|
| Animals | 4 | 2023 | 33862 | 0.130 |
Why?
|
| Wounds and Injuries | 1 | 2021 | 390 | 0.130 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2021 | 470 | 0.130 |
Why?
|
| Immunosuppressive Agents | 1 | 2021 | 665 | 0.130 |
Why?
|
| Leukemia | 1 | 2020 | 374 | 0.130 |
Why?
|
| Bixaceae | 1 | 2016 | 2 | 0.130 |
Why?
|
| ROC Curve | 1 | 2018 | 612 | 0.120 |
Why?
|
| Seeds | 1 | 2016 | 44 | 0.120 |
Why?
|
| Fatty Acids, Monounsaturated | 2 | 2006 | 47 | 0.120 |
Why?
|
| Administration, Oral | 1 | 2018 | 708 | 0.120 |
Why?
|
| Child | 6 | 2022 | 26101 | 0.120 |
Why?
|
| Fluticasone-Salmeterol Drug Combination | 1 | 2015 | 9 | 0.120 |
Why?
|
| Itraconazole | 1 | 2015 | 24 | 0.120 |
Why?
|
| Carotenoids | 1 | 2016 | 77 | 0.120 |
Why?
|
| Budesonide | 1 | 2015 | 18 | 0.120 |
Why?
|
| Histoplasma | 1 | 2015 | 37 | 0.120 |
Why?
|
| Cushing Syndrome | 1 | 2015 | 22 | 0.120 |
Why?
|
| Protein-Losing Enteropathies | 1 | 2015 | 19 | 0.120 |
Why?
|
| Bronchiectasis | 1 | 2015 | 22 | 0.110 |
Why?
|
| Plant Extracts | 1 | 2016 | 128 | 0.110 |
Why?
|
| Pollen | 1 | 2015 | 38 | 0.110 |
Why?
|
| Histoplasmosis | 1 | 2015 | 55 | 0.110 |
Why?
|
| Severe Combined Immunodeficiency | 1 | 2015 | 107 | 0.110 |
Why?
|
| Indoles | 2 | 2006 | 198 | 0.110 |
Why?
|
| Adult | 6 | 2018 | 31179 | 0.110 |
Why?
|
| Penaeidae | 1 | 2004 | 4 | 0.110 |
Why?
|
| Shellfish | 1 | 2004 | 21 | 0.100 |
Why?
|
| Respiratory Mucosa | 1 | 2004 | 93 | 0.100 |
Why?
|
| Hypersensitivity, Immediate | 1 | 2004 | 31 | 0.100 |
Why?
|
| Male | 9 | 2021 | 64488 | 0.100 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2007 | 499 | 0.100 |
Why?
|
| Sensitivity and Specificity | 1 | 2018 | 2105 | 0.100 |
Why?
|
| Cytomegalovirus Infections | 1 | 2004 | 220 | 0.090 |
Why?
|
| Infant | 3 | 2023 | 13234 | 0.090 |
Why?
|
| Female | 8 | 2022 | 70388 | 0.090 |
Why?
|
| Middle Aged | 5 | 2018 | 28438 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 1 | 2004 | 1455 | 0.080 |
Why?
|
| Chemokine CCL17 | 2 | 2007 | 11 | 0.080 |
Why?
|
| Chemokines, CC | 2 | 2007 | 26 | 0.080 |
Why?
|
| Biomarkers | 1 | 2020 | 3388 | 0.080 |
Why?
|
| Interleukin-5 | 2 | 2007 | 50 | 0.080 |
Why?
|
| HIV Infections | 1 | 2021 | 2037 | 0.070 |
Why?
|
| Case-Control Studies | 3 | 2007 | 3380 | 0.070 |
Why?
|
| Aged | 2 | 2018 | 20918 | 0.070 |
Why?
|
| Lymphocyte Activation | 2 | 2007 | 632 | 0.070 |
Why?
|
| Interferon-gamma | 2 | 2007 | 549 | 0.070 |
Why?
|
| Cell Survival | 2 | 2007 | 836 | 0.070 |
Why?
|
| Prevalence | 1 | 2014 | 2699 | 0.070 |
Why?
|
| Interleukin-12 Subunit p40 | 1 | 2007 | 14 | 0.070 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2007 | 68 | 0.060 |
Why?
|
| Interleukin-4 | 1 | 2007 | 145 | 0.060 |
Why?
|
| Coculture Techniques | 1 | 2007 | 232 | 0.060 |
Why?
|
| Interleukin-12 | 1 | 2007 | 124 | 0.060 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2015 | 1267 | 0.060 |
Why?
|
| Neoplasms | 1 | 2021 | 2955 | 0.060 |
Why?
|
| Lung | 1 | 2004 | 1547 | 0.060 |
Why?
|
| Interleukin-10 | 1 | 2007 | 186 | 0.060 |
Why?
|
| Chemokines | 1 | 2006 | 126 | 0.060 |
Why?
|
| Antigens, CD | 1 | 2007 | 411 | 0.060 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2004 | 37 | 0.050 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2006 | 354 | 0.050 |
Why?
|
| Cells, Cultured | 2 | 2007 | 2903 | 0.050 |
Why?
|
| Statistics, Nonparametric | 2 | 2004 | 425 | 0.050 |
Why?
|
| Respiratory Burst | 1 | 2022 | 8 | 0.050 |
Why?
|
| RNA Splice Sites | 1 | 2022 | 92 | 0.040 |
Why?
|
| Severity of Illness Index | 2 | 2004 | 3039 | 0.040 |
Why?
|
| NADPH Oxidases | 1 | 2022 | 109 | 0.040 |
Why?
|
| Cetirizine | 1 | 2021 | 4 | 0.040 |
Why?
|
| Mastocytosis | 1 | 2021 | 7 | 0.040 |
Why?
|
| Twins, Monozygotic | 1 | 2021 | 124 | 0.040 |
Why?
|
| Environment | 1 | 2021 | 149 | 0.040 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2021 | 124 | 0.040 |
Why?
|
| Cytokines | 1 | 2006 | 1342 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2007 | 2469 | 0.040 |
Why?
|
| Reactive Oxygen Species | 1 | 2022 | 521 | 0.040 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2006 | 749 | 0.040 |
Why?
|
| United States | 1 | 2014 | 11871 | 0.040 |
Why?
|
| Apoptosis | 1 | 2005 | 1832 | 0.040 |
Why?
|
| Chimerism | 1 | 2015 | 29 | 0.030 |
Why?
|
| Iatrogenic Disease | 1 | 2015 | 118 | 0.030 |
Why?
|
| Photomicrography | 1 | 2004 | 10 | 0.030 |
Why?
|
| Airway Resistance | 1 | 2004 | 32 | 0.030 |
Why?
|
| Drug Interactions | 1 | 2015 | 236 | 0.030 |
Why?
|
| Basement Membrane | 1 | 2004 | 40 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2020 | 1880 | 0.030 |
Why?
|
| Cell Degranulation | 1 | 2004 | 27 | 0.030 |
Why?
|
| Radioallergosorbent Test | 1 | 2004 | 7 | 0.030 |
Why?
|
| Autopsy | 1 | 2004 | 112 | 0.030 |
Why?
|
| Cell Count | 1 | 2004 | 213 | 0.030 |
Why?
|
| Biopsy, Needle | 1 | 2004 | 206 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2004 | 254 | 0.030 |
Why?
|
| Observer Variation | 1 | 2004 | 309 | 0.030 |
Why?
|
| Immunoglobulin M | 1 | 2004 | 211 | 0.020 |
Why?
|
| China | 1 | 2004 | 279 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 1290 | 0.020 |
Why?
|
| Reference Values | 1 | 2004 | 680 | 0.020 |
Why?
|
| Cytomegalovirus | 1 | 2004 | 257 | 0.020 |
Why?
|
| Weight Gain | 1 | 2015 | 382 | 0.020 |
Why?
|
| DNA, Viral | 1 | 2004 | 452 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2004 | 938 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2004 | 784 | 0.020 |
Why?
|
| Viral Load | 1 | 2004 | 406 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2004 | 1017 | 0.020 |
Why?
|
| Pedigree | 1 | 2015 | 1687 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2004 | 1601 | 0.020 |
Why?
|
| Prognosis | 1 | 2020 | 4880 | 0.020 |
Why?
|
| Phenotype | 1 | 2020 | 4479 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2021 | 3404 | 0.020 |
Why?
|
| Protein Binding | 1 | 2004 | 1660 | 0.020 |
Why?
|
| Proteins | 1 | 2004 | 1014 | 0.020 |
Why?
|
| Phytohemagglutinins | 1 | 2006 | 12 | 0.020 |
Why?
|
| Receptors, CCR4 | 1 | 2006 | 7 | 0.020 |
Why?
|
| Mevalonic Acid | 1 | 2006 | 18 | 0.020 |
Why?
|
| Receptors, CXCR3 | 1 | 2006 | 23 | 0.020 |
Why?
|
| Receptors, Chemokine | 1 | 2006 | 47 | 0.020 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2006 | 92 | 0.010 |
Why?
|
| Chemokines, CXC | 1 | 2006 | 36 | 0.010 |
Why?
|
| Chemokine CXCL10 | 1 | 2006 | 52 | 0.010 |
Why?
|
| Phorbol 12,13-Dibutyrate | 1 | 2005 | 8 | 0.010 |
Why?
|
| Ionomycin | 1 | 2005 | 15 | 0.010 |
Why?
|
| Cytochromes c | 1 | 2005 | 51 | 0.010 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2005 | 64 | 0.010 |
Why?
|
| CD3 Complex | 1 | 2005 | 94 | 0.010 |
Why?
|
| Th2 Cells | 1 | 2006 | 184 | 0.010 |
Why?
|
| Th1 Cells | 1 | 2006 | 158 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2005 | 166 | 0.010 |
Why?
|
| Caspases | 1 | 2005 | 153 | 0.010 |
Why?
|
| Cell Division | 1 | 2006 | 719 | 0.010 |
Why?
|
| Antibodies | 1 | 2005 | 320 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2005 | 654 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2015 | 8518 | 0.010 |
Why?
|
| Cell Line | 1 | 2006 | 2566 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2004 | 12843 | 0.010 |
Why?
|